A NOVEL NQO1 SPECIFIC ANTI-TUMOR AGENT, SBSC-S3001, SELECTIVELY REGRESSES THE GROWTH OF TUMORS WITH HIGH NQO1 EXPRESSION

被引：0
|
作者：
Yun, Minhyuk [1 ]
Kim, Goo-Young [1 ]
Jo, Sang Woo [1 ]
In, Changhoon [1 ]
Moon, Gyu-Young [1 ]
Ko, In Seok [2 ]
Lee, Eun Ju [2 ]
Hong, Yong Rae [2 ]
Lee, Whee Seong [2 ]
Cho, Helen [1 ]
机构：
[1] Samyang Biopharmaceut Corp, Pangyo, South Korea
[2] Lmito Therapeut Inc, Pangyo, South Korea
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2020年 / 8卷
关键词：
D O I：
10.1136/jitc-2020-SITC2020.0734
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
734
引用
收藏
页码：A439 / A439
页数：1
相关论文
共 46 条
  • [21] Novel high throughput pooled shRNA screening identifies NQO1 as a potential drug target for host directed therapy for tuberculosis
    Qing Li
    Ahmad F. Karim
    Xuedong Ding
    Biswajit Das
    Curtis Dobrowolski
    Richard M. Gibson
    Miguel E. Quiñones-Mateu
    Jonathan Karn
    Roxana E. Rojas
    Scientific Reports, 6
  • [22] Sub-chronic sulforaphane exposure in CD-1 pregnant mice enhances maternal NADPH quinone oxidoreductase 1 (NQO1) activity and mRNA expression of NQO1, glutathione S-transferase, and glutamate-cysteine ligase: Potential implications for fetal protection against toxicant exposure
    Philbrook, Nicola A.
    Winn, Louise M.
    REPRODUCTIVE TOXICOLOGY, 2014, 43 : 30 - 37
  • [23] The IGF2BP2-circ-DAPK1 axis promotes high-glucose-induced ferroptosis of HUVECs by decreasing NQO1 expression
    Qiu, Chenyang
    Zheng, Xiangtao
    Zhou, Xiaoxiang
    Wang, Bing
    Chen, Tianchi
    Xu, Yiting
    Yu, Xinyu
    Lu, Wei
    Wu, Ziheng
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2025, 1871 (05):
  • [24] Genetic variants of NQO1 affect the expression and activity of the protein, which determines the efficacy of idebenone treatment in Leber's hereditary optic neuropathy
    Del Dotto, Valentina
    Aleo, Serena J.
    Romagnoli, Martina
    Fiorini, Claudio
    Capirossi, Giada
    Peron, Camille
    Fasano, Chiara
    Maresca, Alessandra
    Caporali, Leonardo
    Capristo, Mariantonietta
    Tropeano, Concetta V.
    Zanna, Claudia
    Porcelli, Anna M.
    Tioli, Gaia
    Amore, Giulia
    La Morgia, Chiara
    Tiranti, Valeria
    Carelli, Valerio
    Ghelli, Anna
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 2024, 1865 : 137 - 137
  • [25] Pharmacokinetics and derivation of an anticancer dosing regimen for the novel anti-cancer agent isobutyl-deoxynyboquinone (IB-DNQ), a NQO1 bioactivatable molecule, in the domestic felid species
    Alycen P. Lundberg
    Joshua M. Francis
    Malgorzata Pajak
    Elizabeth I. Parkinson
    Kathryn L. Wycislo
    Thomas J. Rosol
    Megan E. Brown
    Cheryl A. London
    Levent Dirikolu
    Paul J. Hergenrother
    Timothy M. Fan
    Investigational New Drugs, 2017, 35 : 134 - 144
  • [26] Pharmacokinetics and derivation of an anticancer dosing regimen for the novel anti-cancer agent isobutyl-deoxynyboquinone (IB-DNQ), a NQO1 bioactivatable molecule, in the domestic felid species
    Lundberg, Alycen P.
    Francis, Joshua M.
    Pajak, Malgorzata
    Parkinson, Elizabeth I.
    Wycislo, Kathryn L.
    Rosol, Thomas J.
    Brown, Megan E.
    London, Cheryl A.
    Dirikolu, Levent
    Hergenrother, Paul J.
    Fan, Timothy M.
    INVESTIGATIONAL NEW DRUGS, 2017, 35 (02) : 134 - 144
  • [27] HIGH-LEVELS OF EXPRESSION OF THE NAD(P)H-QUINONE OXIDOREDUCTASE (NQO1) GENE IN TUMOR-CELLS COMPARED TO NORMAL-CELLS OF THE SAME ORIGIN
    CRESTEIL, T
    JAISWAL, AK
    BIOCHEMICAL PHARMACOLOGY, 1991, 42 (05) : 1021 - 1027
  • [28] A high-performance enzyme-activated near-infrared probe for the sensing and tracking of tumor-related NQO1 in cells and in vivo
    Zhang, Yong
    Chen, Xueqian
    Yuan, Qing
    Bian, Yongning
    Li, Mingrui
    Su, Dongdong
    Gao, Xueyun
    SENSORS AND ACTUATORS B-CHEMICAL, 2022, 354
  • [29] Spatial Analysis of NQO1 in Non-Small Cell Lung Cancer Shows Its Expression Is Independent of NRF1 and NRF2 in the Tumor Microenvironment
    Kaghazchi, Boback
    Um, In Hwa
    Elshani, Mustafa
    Read, Oliver J.
    Harrison, David J.
    BIOMOLECULES, 2022, 12 (11)
  • [30] A novel NQO1 bioactivatable drug induces mitochondrial dysfunction and G2/M phase cell cycle arrest to selectively kill pancreatic cancer cells.
    Huang, Xiumei
    Jiang, Lingxiang
    Boudreau, Matthew W.
    Hergenrother, Paul J.
    CANCER RESEARCH, 2022, 82 (12)
12345